Symbol="BCYC"
AssetType="Common Stock"
Name="Bicycle Therapeutics Ltd"
Description="Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, is developing a class of drugs for diseases that are not served by existing treatments. The company is headquartered in Cambridge, the United Kingdom."
CIK="1761612"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="B900 BABRAHAM RESEARCH CAMPUS, CAMBRIDGE, GB"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="830856000"
EBITDA="-141032000"
PERatio="None"
PEGRatio="None"
BookValue="7.2"
DividendPerShare="0"
DividendYield="0"
EPS="-4.75"
RevenuePerShareTTM="0.753"
ProfitMargin="0"
OperatingMarginTTM="-6.52"
ReturnOnAssetsTTM="-0.204"
ReturnOnEquityTTM="-0.527"
RevenueTTM="22518000"
GrossProfitTTM="-67146000"
DilutedEPSTTM="-4.75"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="1.603"
AnalystTargetPrice="48.92"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="61.69"
PriceToBookRatio="3.139"
EVToRevenue="39.3"
EVToEBITDA="-6.12"
Beta="0.72"
num_52WeekHigh="33.49"
num_52WeekLow="18.84"
num_50DayMovingAverage="24.06"
num_200DayMovingAverage="25.0"
SharesOutstanding="36714800"
DividendDate="None"
ExDividendDate="None"
symbol="BCYC"
open="22.67"
high="23.09"
low="21.46"
price="21.74"
volume="316379.00"
latest_trading_day="2023-08-31"
previous_close="22.63"
change="-0.89"
change_percent="-3.9328%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="48"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="52"
Volume_recent_avg="231077"
Change_recent_avg="-0.01"
Delta_recent_avg="1.35"
Variance_recent_avg="0.67"
Change_ratio_recent_avg="-0.09"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="52"
Aroon_momentum_negative="48"
image_negative_thumbnail_id_1="109"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0067.jpeg"
image_negative_thumbnail_id_2="1091"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0124.jpeg"
image_neutral_thumbnail_id_1="577"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0022.jpeg"
image_neutral_thumbnail_id_2="536"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0063.jpeg"
image_positive_thumbnail_id_1="611"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0097.jpeg"
image_positive_thumbnail_id_2="975"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0137.jpeg"
image_professor_thumbnail_id_1="1203"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0037.jpeg"
image_professor_thumbnail_id_2="1204"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0038.jpeg"
